Sansure Biotech Inc. (SHSE:688289) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The shares will be purchased at a price not exceeding CNY 35 per share. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be funded from company's own funds. The program will be valid for 12 months.

On November 23, 2022, the company adjusted the price per share to CNY 34.15 per share.

On June 1, 2023, the company announced that after the 2022 equity distribution, the Company adjusted the maximum repurchase price from not more than CNY 34.15 per share to not more than CNY 33.73 per share.